Punjab Tissue Profile
Key Indicators
- Authorised Capital ₹ 3.50 Cr
as on 09-01-2025
- Paid Up Capital ₹ 3.45 Cr
as on 09-01-2025
- Company Age 36 Year, 19 Days
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 4.93 Cr
as on 09-01-2025
- Revenue %
(FY 2020)
- Profit -221.68%
(FY 2020)
- Ebitda 22.44%
(FY 2020)
- Net Worth 65.79%
(FY 2020)
- Total Assets -23.78%
(FY 2020)
About Punjab Tissue
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.50 Cr and a paid-up capital of Rs 3.45 Cr.
The company has closed loans amounting to ₹4.93 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Kanwaljit Thanewal, Surinder Kumar, Kanwaljit Singh, and One other member serve as directors at the Company.
- CIN/LLPIN
U21012CH1988PLC008918
- Company No.
008918
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
22 Dec 1988
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- LocationU T, Chandigarh
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Punjab Tissue?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kanwaljit Thanewal  | Director | Current | |
| Surinder Kumar | Director | 04-Dec-2020 | Current |
| Kanwaljit Singh | Director | 23-Mar-1996 | Current |
| Trilochan Bagga | Director | 24-Dec-2004 | Current |
Financial Performance of Punjab Tissue.
Punjab Tissue Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 221.68% decrease in profit. The company's net worth Soared by an impressive increase of 65.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Punjab Tissue?
In 2020, Punjab Tissue had a promoter holding of 64.95% and a public holding of 35.06%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sanguine Corporate Services Opc Private LimitedActive 8 years 10 monthsKanwaljit Thanewal is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bnak Of Patiala Creation Date: 17 Jan 1995 | ₹1.93 Cr | Satisfied |
Punjab State Industrial Development Corporation Ltd. Creation Date: 23 May 1994 | ₹1.50 M | Satisfied |
Punjab Financial Corporation Creation Date: 24 Apr 1991 | ₹7.50 M | Satisfied |
How Many Employees Work at Punjab Tissue?
Unlock and access historical data on people associated with Punjab Tissue, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Punjab Tissue, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Punjab Tissue's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
